People, Before Profits: India’s Patent Law Under Attack
The deal is one of a number of bilateral trade agreements underway between Europe and other developing countries that contain such potentially damaging provisions.
21 articles related to "Patent Disputes"
New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...
Statements, Speeches, Letters – Last updated 04 March 2013
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
Patent Information & Transparency : A Methodology for Patent Searches on Essential Medicines in Developing Countries
A report by UNDP, co-authored by MSF's Barbara Milani, lays out a four-step methodolgy for conducting patent searches in developing countries providing an inexpensive and pragmatic option to perform...
Report – Last updated 12 July 2012
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012
Novartis and Bayer are both charging exhorbitant prices for medicines in India as they continue their fight against the country's patent law that puts people over profits in the name of access to...
Web article – Last updated 11 September 2012
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 21 August 2012
Médecins Sans Frontières (MSF) has learnt this morning that final arguments in the Indian Supreme Court case of Novartis vs. Government of India has been re-scheduled for 11 September...
Web article – Last updated 22 August 2012
Hearings in the case opposing Swiss pharmaceutical company Novartis and the Indian government are now set to start on 28 March. The Novartis Supreme Court case is the final act in a legal battle...
Web article – Last updated 01 March 2012
1994 – India signs the World Trade Organization (WTO)‘s Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement) which means that it must now start granting patents...
Web article – Last updated 13 February 2012
Novartis has been pursuing a legal case aimed at gutting India’s patent law of important public health safeguards since 2006. The law allows companies in India to produce affordable generic medicines...
Web article – Last updated 07 December 2011